Fundz
Real-time · AI · Cross-signal

Bavarian Nordic just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Bavarian Nordic, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Bavarian Nordic partners with Serum Institute for Mpox vaccine production

Dec 16, 2024•over 1 year ago

Contract Type

partnership

BiotechnologyHealth Care

Description

Bavarian Nordic has entered into a partnership with Serum Institute to collaborate on the production of the Mpox vaccine.

Company Information

Company

Bavarian Nordic

About

Bavarian Nordic is a biotechnology company focused on developing and producing innovative vaccines. The company's portfolio includes treatments for infectious diseases and cancer. It is publicly traded and based in Denmark.

Predictive Intelligence
Strategic

ML-powered predictions for Bavarian Nordic's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months